Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence

NCT06078969 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis of Bone

Interventions

DRUG: Prednisone

Sponsor

Shanghai Changzheng Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]